The
Institute Gustave Roussy was founded by
Professor Gustave Roussy, the father of the concepts of «cross-boundary working » and «multi-disciplinary patient management». For 70 years, this specialized Center has been developing an approach to oncology which remains faithful to its founder's values: innovation, dynamism, cooperation and benevolence. All of this is built on the three guiding principles: patient care, research and teaching.
Care : Gustave Roussy's teams innovate in care, to organize shorter care pathways and offer very high quality care, less invasive and increasingly personalized. The Institute provides medical oncology, chemotherapy, radiotherapy, surgery, interventional radiology and reconstructive surgery and has high-tech infrastructures: robotic surgery, renewed ambulatory surgery tray, completely revised radiotherapy tray, chemotherapy preparation robots, genomics. Gustave Roussy is the European leader for early trials and offers patients access to innovative medicines within very short deadlines.
Research : The Institute is organized as an integrated center for fundamental, translational and clinical research. This approach is a source of therapeutic innovations. Gustave Roussy mainly focuses his research on personalized medicine, immunotherapy and DNA repair. Gustave Roussy is the leading European center for personalized medicine and immunotherapy.
Teaching : The Institut Gustave Roussy is involved in passing on its oncological expertise by training doctors, research scientists, nurses, students and all health professional caring for cancer patients. Its high-level educational programs are delivered by international experts.The
École des Sciences du Cancer was set up in 2012 by Gustave Roussy and
Paris-Sud University. It is one-of-its-kind in France and educates students for the new types of competences required in oncology.